Automated microfluidic device for the separation of cancer cells from blood

The ability to separate cells based on biomechanical properties such as size and deformability is emerging as a potential alternative to biochemical methods for cell separation, particularly in cases where biochemical markers are unknown or expressed at low levels. The separation of circulating tumo...

Full description

Bibliographic Details
Main Author: Lin, Bill Kengli
Language:English
Published: University of British Columbia 2012
Online Access:http://hdl.handle.net/2429/43737
id ndltd-UBC-oai-circle.library.ubc.ca-2429-43737
record_format oai_dc
spelling ndltd-UBC-oai-circle.library.ubc.ca-2429-437372018-01-05T17:26:20Z Automated microfluidic device for the separation of cancer cells from blood Lin, Bill Kengli The ability to separate cells based on biomechanical properties such as size and deformability is emerging as a potential alternative to biochemical methods for cell separation, particularly in cases where biochemical markers are unknown or expressed at low levels. The separation of circulating tumor cells (CTCs) is an example problem where this type of technology is important because the cell surface markers currently used to capture these cells are known to be unreliable. The performance of existing biomechanical cell separation techniques is currently hindered by clogging, which reduces specificity of the separation process. We previously demonstrated a microfluidic ratchet mechanism that overcomes the reversible nature of low Reynolds number flow. In this thesis, we leverage this mechanism to prevent clogging while preserving high selectivity by periodically clearing the filter microstructure to create an automated microfluidic platform that demonstrates the size and deformability-based separation of cultured human bladder UC13 cancer cells from white blood cells (WBCs). This platform has two components: the first is a size-based hydrodynamic concentrator, which performs an initial sample preparation step to reduce the sample volume while removing a fraction of the contaminant WBCs. The second is an automated cell separation device where cells are transported through a 2D array of ratcheting funnel constrictions and sorted using an oscillatory flow. We evaluate the ability of this platform for separating rare cancer cells doped into WBCs at low concentration to assess the potential of this technology for biomechanical separation of CTCs. Specifically, using a sample where cancer cells are doped into WBCs at a ratio of 1:1000, the combined system achieved a cancer cell yield of 96.0±0.1%; the outlet had a purity of 75±3%; and the population of cancer cells in the mixture was enriched by a factor 3000 (+643, -278). Applied Science, Faculty of Mechanical Engineering, Department of Graduate 2012-12-20T22:08:09Z 2012-12-20T22:08:09Z 2012 2013-05 Text Thesis/Dissertation http://hdl.handle.net/2429/43737 eng Attribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/ University of British Columbia
collection NDLTD
language English
sources NDLTD
description The ability to separate cells based on biomechanical properties such as size and deformability is emerging as a potential alternative to biochemical methods for cell separation, particularly in cases where biochemical markers are unknown or expressed at low levels. The separation of circulating tumor cells (CTCs) is an example problem where this type of technology is important because the cell surface markers currently used to capture these cells are known to be unreliable. The performance of existing biomechanical cell separation techniques is currently hindered by clogging, which reduces specificity of the separation process. We previously demonstrated a microfluidic ratchet mechanism that overcomes the reversible nature of low Reynolds number flow. In this thesis, we leverage this mechanism to prevent clogging while preserving high selectivity by periodically clearing the filter microstructure to create an automated microfluidic platform that demonstrates the size and deformability-based separation of cultured human bladder UC13 cancer cells from white blood cells (WBCs). This platform has two components: the first is a size-based hydrodynamic concentrator, which performs an initial sample preparation step to reduce the sample volume while removing a fraction of the contaminant WBCs. The second is an automated cell separation device where cells are transported through a 2D array of ratcheting funnel constrictions and sorted using an oscillatory flow. We evaluate the ability of this platform for separating rare cancer cells doped into WBCs at low concentration to assess the potential of this technology for biomechanical separation of CTCs. Specifically, using a sample where cancer cells are doped into WBCs at a ratio of 1:1000, the combined system achieved a cancer cell yield of 96.0±0.1%; the outlet had a purity of 75±3%; and the population of cancer cells in the mixture was enriched by a factor 3000 (+643, -278). === Applied Science, Faculty of === Mechanical Engineering, Department of === Graduate
author Lin, Bill Kengli
spellingShingle Lin, Bill Kengli
Automated microfluidic device for the separation of cancer cells from blood
author_facet Lin, Bill Kengli
author_sort Lin, Bill Kengli
title Automated microfluidic device for the separation of cancer cells from blood
title_short Automated microfluidic device for the separation of cancer cells from blood
title_full Automated microfluidic device for the separation of cancer cells from blood
title_fullStr Automated microfluidic device for the separation of cancer cells from blood
title_full_unstemmed Automated microfluidic device for the separation of cancer cells from blood
title_sort automated microfluidic device for the separation of cancer cells from blood
publisher University of British Columbia
publishDate 2012
url http://hdl.handle.net/2429/43737
work_keys_str_mv AT linbillkengli automatedmicrofluidicdevicefortheseparationofcancercellsfromblood
_version_ 1718583639881547776